Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
Where
Changchun, Harbin, Hefei, Shanghai, Wuhan
Age
18 years and over
People
54
Run by
Abbisko Therapeutics Co, Ltd
See details and how to joinNCT06668103
No phaseEnrolling by invitation
Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma
Where
Wuhan
Age
18 years to 80 years
People
500
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06730477
No phaseTaking people
Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer
Where
Shanghai
Age
18 years and over
People
250
Run by
Shanghai Chest Hospital
See details and how to joinNCT06730503
Phase 2Taking people
Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study
Where
Guangzhou
Age
18 years to 70 years
People
32
Run by
Li-kun Chen
See details and how to joinNCT06728852
No phaseTaking people
The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.
Where
Guangzhou
Age
18 years to 75 years
People
500
Run by
Sun Yat-sen University
See details and how to joinNCT06019455
Phase 2Not yet taking people in China
A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors
Where
Shanghai
Age
18 years and over
People
120
Run by
Tasly Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06724263
Phase 2Taking people
Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC
Where
Hangzhou
Age
18 years and over
People
40
Run by
First People's Hospital of Hangzhou
See details and how to joinNCT06718309
No phaseTaking people
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
Where
Changsha
Age
18 years and over
People
210
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT05598528
No phaseTaking people
Molecular Analysis and Treatment Options of SCLC
Where
Shanghai
Age
18 years and over
People
500
Run by
Shanghai Chest Hospital
See details and how to joinNCT05945745
No phaseNot yet taking people in China
Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC
Where
Changsha, Chengdu, Dongguan, Foshan, Guangzhou, Guiyang, Nanjing, Nanning, Nantong, Shenzhen, Wuhan
Age
18 years to 75 years
People
342
Run by
Guangdong Association of Clinical Trials
See details and how to joinNCT06709274
Phase 2Taking people
Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer
Where
Changsha, Guangzhou
Age
18 years and over
People
200
Run by
BeBetter Med Inc
See details and how to joinNCT06706713
No phaseTaking people
Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
Where
Beijing
Age
18 years to 75 years
People
20
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT06648317
Phase 2Taking people
Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases
Where
Changsha
Age
18 years to 75 years
People
20
Run by
Rongrong Zhou
See details and how to joinNCT06702826
Phase 2Taking people
Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin
Where
Shanghai
Age
18 years and over
People
52
Run by
Shanghai Chest Hospital
See details and how to joinNCT06698965
Phase 1Taking people
Study of High Efficient Killing Cell Therapy for Advanced NSCLC
Where
Shanghai
Age
18 years to 70 years
People
15
Run by
Ruijin Hospital
See details and how to joinNCT03193567
No phaseTaking people
Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer
Where
Shanghai
Age
18 years to 75 years
People
20
Run by
Ruijin Hospital
See details and how to joinNCT04973293
Phase 1Taking people
Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer
Where
Changsha
Age
18 years to 75 years
People
6
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT05979818
Phase 2Taking people
A Phase 2 Clinical Study of ABSK061 and ABSK043
Where
Changsha, Changzhi, Chengdu, Guiyang, Hangzhou, Harbin, Jinan, Nanchang, Shanghai, Shenyang, Shijiazhuang, Tianjin, Wuhan, Xiamen, Xi'an, Xiangyang, Xuzhou, Zhengzhou
Age
18 years and over
People
202
Run by
Abbisko Therapeutics Co, Ltd
See details and how to joinNCT06632262
Phase 2Taking people
Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression
Where
Guangzhou, Shanghai
Age
18 years and over
People
29
Run by
Ruijin Hospital
See details and how to joinNCT06269211
Phase 1/2Not yet taking people in China
A Single-Arm, Phase Ⅰb Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated NSCLC
Where
Shanghai
Age
18 years and over
People
30
Run by
Shanghai Chest Hospital
See details and how to joinNCT06690671
Phase 2Not yet taking people in China
Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLC
Where
Shanghai
Age
18 years and over
People
30
Run by
Shanghai Chest Hospital
See details and how to joinNCT06688656
No phaseEnrolling by invitation
Perioperative Treatment Outcomes of Early NSCLC
Where
Shanghai
People
500
Run by
Shanghai Chest Hospital
See details and how to joinNCT06610240
Phase 1/2Taking people
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer
Where
Beijing
Age
16 years to 90 years
People
75
Run by
Essen Biotech
See details and how to joinNCT06532799
No phaseTaking people
AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases
Where
Shanghai
Age
18 years and over
People
800
Run by
Fudan University
See details and how to joinNCT06604689
Phase 2Taking people
ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI
Where
Beijing
Age
18 years to 80 years
People
27
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06388031